Your Thyroid Isn’t the Problem. The Way We Test It Might Be.

Of all the conversations I have with patients who’ve spent years feeling unwell, the ones about thyroid function are the most frustrating — not because the thyroid is complicated, but because the answers have been sitting in the research for years while the clinical approach hasn’t moved.

Here’s a scene I’ve watched play out more times than I can count: a patient — usually a woman in her 30s, 40s, or 50s — comes in exhausted. Not just tired. Bone-tired. She’s gained weight without explanation. Her hair is thinning. Her thinking feels sluggish, her mood flat, her body cold in ways it didn’t used to be. She’s had her thyroid checked. She was told it’s normal. And yet there she is, sitting across from me, describing a body that is clearly not functioning normally.

The thyroid is one of the most mismanaged systems in conventional medicine. And the reason is almost always the same: we’re asking the wrong questions, using the wrong benchmarks, and applying the same answers to problems that are not the same.

The Thyroid: What It Actually Does

The thyroid gland sits at the base of the neck and functions as the body’s master metabolic regulator. It produces two primary hormones — thyroxine (T4) and triiodothyronine (T3) — that govern how every cell in the body produces and uses energy. Temperature regulation, heart rate, metabolism, digestion, cognitive function, mood, hair growth, reproductive health, bone density — all of it runs downstream of proper thyroid hormone signaling.

When the thyroid produces too little hormone, we call it hypothyroidism. Too much, and it’s hyperthyroidism. Both conditions disrupt the entire hormonal ecosystem in cascading ways that go well beyond what a single lab value can capture.

Understanding thyroid dysfunction — truly understanding it — requires looking at the whole system, not just the gland.

Hypothyroidism: The Most Underdiagnosed Condition You’ve Never Heard the Full Story On

Hypothyroidism has historically been estimated to affect about 4.6% of the U.S. population. Recent data now puts that figure as high as 11.7% — and that’s just the diagnosed cases. The actual number of people walking around with suboptimal thyroid function who have been told their labs are normal is almost certainly higher still.

The most common cause of hypothyroidism in the United States is Hashimoto’s thyroiditis — an autoimmune condition in which the immune system attacks the thyroid gland as if it were a foreign invader. This is not simply a gland “wearing out.” It is an immune system dysfunction, and treating it without addressing the immune component is like mopping the floor while the faucet is still running.

Symptoms of hypothyroidism include:

•       Persistent fatigue and low energy that doesn’t improve with rest

•       Unexplained weight gain or difficulty losing weight despite diet and exercise

•       Brain fog, poor concentration, and memory issues

•       Depression, flat affect, and emotional blunting

•       Hair thinning or loss, including from the outer third of the eyebrows

•       Cold intolerance — feeling cold when others around you don’t

•       Dry skin, brittle nails, and hoarse voice

•       Constipation and slow digestion

•       Elevated cholesterol

•       Irregular or heavy menstrual cycles

The insidious part is that many of these symptoms are attributed to stress, aging, depression, or “just how things are.” Patients are frequently handed a prescription for an antidepressant when what they actually need is a properly evaluated thyroid workup.

Hyperthyroidism: When the System Is Running Too Hot

On the opposite end, hyperthyroidism occurs when the thyroid produces excess hormone, sending the body’s metabolism into overdrive. The most common cause is Graves’ disease, another autoimmune condition — one in which antibodies actually stimulate the thyroid to overproduce rather than attack and destroy it.

Symptoms of hyperthyroidism include:

•       Unintentional weight loss despite a normal or increased appetite

•       Rapid or irregular heartbeat (palpitations)

•       Heat intolerance and excessive sweating

•       Anxiety, irritability, and nervousness

•       Hand tremors

•       Frequent bowel movements

•       Fatigue and muscle weakness

•       Sleep disturbances

•       In Graves’ disease specifically, thyroid eye disease occurs in up to 40% of patients

The cardiovascular dimension of hyperthyroidism is serious and often underappreciated. Both under and over-treatment of thyroid conditions are associated with increased heart problems and elevated mortality risk. This is not a condition to manage casually.

The TSH Problem — And Why “Normal” Is a Moving Target

Here is where I need to challenge something you’ve almost certainly been told.

TSH — thyroid-stimulating hormone — is a pituitary hormone that signals the thyroid to produce more or less hormone. It’s the primary test used in conventional medicine to evaluate thyroid function, and it is used in isolation far more often than it should be.

The problem is structural. Currently, labs use a single, population-based reference range for TSH across all adults, regardless of age, sex, symptom burden, or individual biology. A 2024 study published in Thyroid by Jansen et al. specifically called this out, establishing that TSH and free T4 levels change with age and recommending age-specific reference intervals to optimize diagnosis. The research is clear: applying a one-size range to a 32-year-old and a 68-year-old is not good medicine.

The standard population-based TSH range is broad by design — it’s derived by measuring TSH levels across a large group of “healthy” people. But as a November 2024 study in Thyroid noted, serum TSH levels vary significantly between individuals, and genetic factors play a meaningful role in what is actually “normal” for a given person. The same study proposed that personalized, genetically informed TSH reference ranges may ultimately be needed to reflect true individual thyroid status.

And then there’s the 15% problem. Research consistently shows that 15% of patients on levothyroxine continue to experience hypothyroid symptoms — fatigue, brain fog, cognitive slowing — despite achieving a TSH level within the laboratory’s normal range. Their labs say they’re treated. Their bodies say otherwise. The research acknowledges this gap. Mainstream clinical practice largely ignores it.

What this tells me is that TSH alone is an incomplete picture. I don’t treat TSH. I treat people.

The T4-to-T3 Conversion Gap Most Providers Miss

Here is a distinction that rarely gets explained to patients, and it’s one of the most important in all of thyroid medicine.

The thyroid gland primarily produces T4 — the storage form of thyroid hormone. T4 is largely inactive. Before the body’s cells can use it, it must be converted to T3, the biologically active form, by enzymes called deiodinases. This conversion happens primarily in the liver, kidneys, and gut.

Levothyroxine — the medication almost universally prescribed for hypothyroidism — is synthetic T4. The implicit assumption is that the patient’s body will efficiently convert it to T3. For many patients, that assumption holds. For a meaningful subset, it doesn’t.

A 2024 randomized controlled trial published in the European Journal of Endocrinology (the LEVOLIO study) found that T4 therapy alone failed to normalize the FT3/FT4 ratio in more than 70% of patients with hypothyroidism following thyroidectomy. A more normal ratio was consistently seen with T4+T3 combination therapy.

A 2025 randomized clinical trial protocol published in Trials proposed that combination therapy using slow-release liothyronine (T3) plus levothyroxine (T4) more closely mimics the natural serum levels of both hormones and the physiological T3/T4 ratio than levothyroxine alone — and the authors noted that genetic polymorphism testing may identify which patients are not responding well to levothyroxine and would benefit most from combination therapy.

This is not fringe medicine. The European Thyroid Association’s consensus guidelines allow for a trial of combination T4/T3 therapy in patients who have persistent symptoms despite optimized levothyroxine dosing. The American Thyroid Association acknowledges the same. What’s missing is not the evidence — it’s the clinical follow-through.

In my practice, when a patient is optimally dosed on levothyroxine and still doesn’t feel right, we don’t increase the dose and declare success. We look deeper. We check free T3. We evaluate the conversion pathway. And when indicated, we explore combination therapy to restore a more physiological hormonal balance.

The Gut-Thyroid Axis: The Connection Nobody Told You About

One of the most important paradigm shifts in thyroid medicine over the past several years is the recognition of what researchers are now calling the gut-thyroid axis.

A January 2025 review published in Gut Microbes Reports confirmed that gut bacteria communicate directly with immune cells — either calming or inflaming the autoimmune response against the thyroid. A 2024 study in Frontiers in Nutrition found that specific gut bacteria, including Akkermansia and Ruminococcaceae, exhibit protective effects against hypothyroidism, while others are actively detrimental. A 2025 systematic review in Biochemistry and Biophysics Reports confirmed that people with Hashimoto’s thyroiditis consistently have lower selenium levels, and that selenium supplementation reduces the thyroid antibodies that drive the autoimmune attack on the gland.

The mechanism becomes even clearer when you look at what the gut does for thyroid function at a biochemical level. The gut microbiome governs the absorption of the nutrients the thyroid depends on most: iodine for hormone synthesis, selenium for T4-to-T3 conversion, zinc and iron for receptor sensitivity and TPO enzyme activity. When the gut ecosystem is disrupted — by poor diet, chronic stress, antibiotic exposure, or inflammation — that nutrient pipeline breaks down. The thyroid begins to starve for the raw materials it needs, regardless of what a TSH value says.

This means that in many cases, treating a thyroid condition without addressing the gut is treating a symptom while ignoring a cause.

What a Precision Medicine Approach Actually Looks Like

When I evaluate a patient for thyroid dysfunction, the conversation is different from what most have experienced. Here’s what I look at and why:

A complete thyroid panel — not just TSH. I routinely check TSH, free T4, free T3, reverse T3, TPO antibodies, and thyroglobulin antibodies. Each marker tells a different part of the story. Reverse T3 can indicate that the body is shunting inactive hormone as a stress response. TPO and thyroglobulin antibodies tell me whether we’re dealing with an autoimmune process — which changes the treatment strategy entirely.

Age- and sex-appropriate interpretation. I don’t apply a blanket population range to a 42-year-old woman with symptoms. I interpret her values in the context of her age, her symptom picture, and her overall hormonal environment.

The conversion pathway. A free T3 that’s low-normal in the context of adequate T4 tells me conversion may be impaired. That leads to a conversation about the gut, selenium status, and whether combination therapy is appropriate.

Gut health and nutrient status. For patients with Hashimoto’s or persistent hypothyroid symptoms on adequate medication, I look at gut health, selenium and zinc levels, vitamin D (a critical immune regulator), and inflammatory markers. Treating the autoimmune component of thyroid disease requires attending to the immune system — and the immune system lives largely in the gut.

The full hormonal context. The thyroid doesn’t operate in isolation. It interacts closely with adrenal function, sex hormones, and insulin sensitivity. A patient whose cortisol is chronically elevated will have impaired T4-to-T3 conversion. I look at the whole system because that’s where the answers live.

A Word on Hyperthyroidism and Getting the Balance Right

For patients on the other end of the spectrum — those with hyperthyroidism or Graves’ disease — the precision medicine approach matters just as much, in different ways.

Conventional management of Graves’ disease typically involves antithyroid drugs, radioactive iodine therapy, or surgery. Each has its place. What’s often missing is attention to the autoimmune driver — because Graves’ disease, like Hashimoto’s, is an immune system problem that happens to express itself in the thyroid. Managing it without addressing immune dysregulation, gut health, stress physiology, and nutrient status is incomplete.

The research also flags an important risk on the treatment side: over-treatment with thyroid hormone in hypothyroid patients — a condition called iatrogenic hyperthyroidism — occurs more commonly than it should, particularly in women, and carries real cardiovascular risk. Getting the balance right requires ongoing, calibrated attention, not a once-a-year TSH check and a refill.

The Bottom Line

Your thyroid is not an isolated gland doing one job. It is the metabolic center of a complex, interconnected hormonal system that touches virtually every function of the body. Treating it as a simple on/off switch — check TSH, prescribe levothyroxine, mark resolved — leaves too many people feeling awful despite being told their labs are fine.

The research being published right now is clear about what a better approach looks like: age-specific hormone ranges, individualized interpretation, complete thyroid panels, assessment of T3 conversion, attention to autoimmunity and gut health, and a willingness to use combination hormone therapy when indicated.

This is not experimental. This is what modern endocrinology looks like when it’s done carefully and with the patient at the center.

If you’ve been told your thyroid is “fine” but you don’t feel fine — that gap between your lab result and your lived experience is worth investigating. In my practice, that gap almost always has an explanation. And more often than not, it has a solution.

Precision Health specializes in comprehensive thyroid evaluation and hormone optimization for patients in Castle Rock and the surrounding Denver metro area. Visit precisionhealthcr.com/appointment to schedule a consultation with Jill.

Sources

Jansen HI et al., “Age-specific reference intervals for thyroid-stimulating hormones and free thyroxine,” Thyroid, Epub September 2024.

Kuś A et al., “Towards personalized TSH reference ranges: a genetic and population-based approach,” Thyroid, Epub June 2024.

Brigante G et al., “Randomized double-blind placebo-controlled trial on levothyroxine and liothyronine combination therapy (LEVOLIO study),” European Journal of Endocrinology, 2024.

Tessnow AH et al., “Treatment of hypothyroidism by age and sex in the United States,” Endocr Pract, 2025.

Gut Microbes Reports, January 2025; Frontiers in Nutrition, 2024; Biochemistry and Biophysics Reports systematic review, 2025.

Tandfonline: “Bridging Microbiomes: Exploring Oral and Gut Microbiomes in Autoimmune Thyroid Diseases,” January 2025.

Adams R and Mammen JS, “Sex Differences in Risk for Iatrogenic Thyrotoxicosis Among Older Adults,” Thyroid, 2025.